Skip to main content
SpringerLink
Log in

Other Tumors

  • Chapter
Pediatric PET Imaging

  • 972 Accesses

Abstract

Positron emission tomography (PET) is a new and powerful imaging tool that has been successfully employed to diagnose many adult tumors. Incidental tumor detection by PET has been reported (1-5), as well as detection of chronic cholecystitis, aspiration pneumonia, and other benign conditions (6-8). The implementation of this new technology has been slower in the pediatric population than in the adult population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ramos CD, Chisin R, Yeung HW, Larson SM, Macapinlac HA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001;26:193–197.

    Article  CAS  PubMed  Google Scholar 

  2. Davis PW, Perrier ND, Adler L, Levine EA. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg 2001;67:582–584.

    CAS  PubMed  Google Scholar 

  3. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783–787.

    Article  PubMed  Google Scholar 

  4. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18FFDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 2004;45: 1804–1810.

    PubMed  Google Scholar 

  5. Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 2004;230:417–422.

    Article  PubMed  Google Scholar 

  6. Yu JQ, Kumar R, Xiu Y, Alavi A, Zhuang H. Diffuse FDG uptake in the lungs in aspiration pneumonia on positron emission tomographic imaging. Clin Nucl Med 2004;29:567–568.

    Article  PubMed  Google Scholar 

  7. Yu JQ, Kung JW, Potenta S, Xiu Y, Alavi A, Zhuang H. Chronic cholecystitis detected by FDG-PET. Clin Nucl Med 2004;29:496–497.

    Article  PubMed  Google Scholar 

  8. Yu JQ, Zhuang H, Xiu Y, Talati E, Alavi A. Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. Clin Nucl Med 2004;29:209–210.

    Article  PubMed  Google Scholar 

  9. Reiman RE, Benua RS, Gelbard AS, Allen JC, Vomero JJ, Laughlin JS. Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication. J Nucl Med 1982;23:682–687.

    CAS  PubMed  Google Scholar 

  10. Mineura K, Yasuda T, Kowada M, et al. Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case. Pediatr Neurosci 1985;12:208–212.

    Article  PubMed  Google Scholar 

  11. Mineura K, Yasuda T, Suda Y, Kowada M, Shishido F, Uemura K. Ewing’s sarcoma with intracranial metastasis presenting depressed cerebral blood flow and metabolism in the contralateral gray matter. Comput Med Imaging Graph 1989;13:185–190.

    Article  CAS  PubMed  Google Scholar 

  12. Chugani HT, Mazziotta JC, Phelps ME. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989;114:244–253.

    Article  CAS  PubMed  Google Scholar 

  13. Shulkin BL, Mitchell DS, Ungar DR, et al. Neoplasms in a pediatric population: 2–[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995; 194:495–500.

    CAS  PubMed  Google Scholar 

  14. Hung GU, Tan TS, Kao CH, Wang SJ. Multiple skeletal metastases of Ewing’s sarcoma demonstrated on FDG-PET and compared with bone and gallium scans. Kaohsiung J Med Sci 2000;16:315–318.

    CAS  PubMed  Google Scholar 

  15. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR 2001;177:229–236.

    CAS  PubMed  Google Scholar 

  16. Hawkins DS, Rajendran JG, Conrad EU 3rd, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]- fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94: 3277–3284.

    Article  CAS  PubMed  Google Scholar 

  17. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000;25:874–881.

    Article  CAS  PubMed  Google Scholar 

  18. Franzius C, Schulte M, Hillmann A, et al. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference, “PET in Oncology”: results of the Bone and Soft Tissue Study Group]. Chirurg 2001;72: 1071–1077.

    Article  CAS  PubMed  Google Scholar 

  19. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR 2005;184:1293–1304.

    PubMed  Google Scholar 

  20. Kaplan AM, Chen K, Lawson MA, Wodrich DL, Bonstelle CT, Reiman EM. Positron emission tomography in children with neurofibromatosis-1. J Child Neurol 1997;12:499–506.

    Article  CAS  PubMed  Google Scholar 

  21. Yu J, Shrikanthan S, Dontu V, et al. FDG-PET imaging in the assessment of disease activity in patients with plexiform neurofibromatosis. (abstr). J Nucl Med 2004;45:34.

    Google Scholar 

  22. Yu J, Shrikanthan S, Dontu V, et al. PET experience with plexiform neurofibromatosis: a preliminary data. Clin Nucl Med 2004;29:139.

    Google Scholar 

  23. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002; 62:1573–1577.

    CAS  PubMed  Google Scholar 

  24. Ferner RE, Lucas JD, O’Doherty MJ, et al. Evaluation of (18) fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 2000;68:353–357.

    Article  CAS  PubMed  Google Scholar 

  25. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992;33:1125–1131.

    CAS  PubMed  Google Scholar 

  26. Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B. Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 2004;230: 423–428.

    Article  PubMed  Google Scholar 

  27. Ott RJ, Tait D, Flower MA, Babich JW, Lambrecht RM. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography. Br J Radiol 1992;65:787–791.

    Article  CAS  PubMed  Google Scholar 

  28. . Musholt TJ, Musholt PB, Dehdashti F, Moley JF. Evaluation of fluorodeoxyglucose- positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 1997; 122:1049–1060; discussion 1060–1061.

    Article  CAS  PubMed  Google Scholar 

  29. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186: 711–715.

    CAS  PubMed  Google Scholar 

  30. Neumann DR, Basile KE, Bravo EL, Chen EQ, Go RT. Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb. J Comput Assist Tomogr 1996;20:312–316.

    Article  CAS  PubMed  Google Scholar 

  31. Bergstrom M, Juhlin C, Bonasera TA, et al. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med 2000;41:275–282.

    CAS  PubMed  Google Scholar 

  32. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315–329.

    CAS  PubMed  Google Scholar 

  33. Pacak K, Goldstein DS, Doppman JL, Shulkin BL, Udelsman R, Eisenhofer G. A “pheo” lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab 2001;86:3641–3646.

    Article  CAS  PubMed  Google Scholar 

  34. Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 2005;257:60–68.

    Article  CAS  PubMed  Google Scholar 

  35. Ilias I, Yu J, Carrasquillo JA, et al. Superiority of 6–[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003;88:4083–4087.

    Article  CAS  PubMed  Google Scholar 

  36. Hoegerle S, Nitzsche E, Altehoefer C, et al. Pheochromocytomas: detection with 18F DOPA whole body PET-initial results. Radiology 2002;222: 507–512.

    Article  PubMed  Google Scholar 

  37. Zettinig G, Mitterhauser M, Wadsak W, et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta- hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 2004; 31:1224–1230.

    Article  PubMed  Google Scholar 

  38. Lenz T, Gossmann J, Schulte KL, Salewski L, Geiger H. Diagnosis of pheochromocytoma. Clin Lab 2002;48:5–18.

    PubMed  Google Scholar 

  39. Ilias I, Pacak K. Anatomical and functional imaging of metastatic pheochromocytoma. Ann N Y Acad Sci 2004;1018:495–504.

    Article  CAS  PubMed  Google Scholar 

  40. Maurea S, Caraco C, Klain M, Mainolfi C, Salvatore M. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques. Q J Nucl Med Mol Imaging 2004;48: 188–197.

    CAS  PubMed  Google Scholar 

  41. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005;4:61–68.

    Article  CAS  PubMed  Google Scholar 

  42. Minn H, Salonen A, Friberg J, et al. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 2004;45: 972–979.

    CAS  PubMed  Google Scholar 

  43. Zhuang H, Yu J, Dadparvar S, et al. Accuracy of FDG-PET in the evaluation of metastatic or recurrent tumors which are candidates for Octreoscan (abstract). J Nucl Med 2003;44:73.

    Google Scholar 

  44. Sasi OA, Sathiapalan R, Rifai A, et al. Colonic neuroendocrine carcinoma in a child. Pediatr Radiol 2005;35:339–343.

    Article  PubMed  Google Scholar 

  45. Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med 2004;29:86–90.

    Article  PubMed  Google Scholar 

  46. Ribeiro MJ, De Lonlay P, Delzescaux T, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005;46:560–566.

    PubMed  Google Scholar 

  47. Shang JB, Li YH, Liu FY, et al. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alphafetoprotein]. Di Yi Jun Yi Da Xue Xue Bao 2004;24:697–699.

    PubMed  Google Scholar 

  48. Bohm B, Voth M, Geoghegan J, et al. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 2004;130:266–272.

    Article  CAS  PubMed  Google Scholar 

  49. Wilson CB, Young HE, Ott RJ, et al. Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management. Eur J Nucl Med 1995;22:508–513.

    Article  CAS  PubMed  Google Scholar 

  50. Okamura T, Kawabe J, Kobashi T, et al. [A case of peritoneal metastasis from retroperitoneal yolk sac tumor diagnosed by 67Ga-scan and 18F-FDGPET]. Kaku Igaku 1995;32:495–499.

    CAS  PubMed  Google Scholar 

  51. Bachor R, Kocher F, Gropengiesser F, Reske SN, Hautmann RE. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results]. Urologe A 1995;34:138–142.

    CAS  PubMed  Google Scholar 

  52. Cremerius U, Effert PJ, Adam G, et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 1998;39:815–822.

    CAS  PubMed  Google Scholar 

  53. Nuutinen JM, Leskinen S, Elomaa I, et al. Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 1997;33: 1234–1241.

    Article  CAS  PubMed  Google Scholar 

  54. Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C. Postchemotherapy resections of residual masses from metastatic nonseminomatous testicular germ cell tumors. Ann Oncol 1997;8:531–538.

    Article  CAS  PubMed  Google Scholar 

  55. Stephens AW, Gonin R, Hutchins GD, Einhorn LH. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996;14: 1637–1641.

    CAS  PubMed  Google Scholar 

  56. Hain SF, O’Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 2000;27:590–594.

    Article  CAS  PubMed  Google Scholar 

  57. Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 2002;89:549–556.

    Article  CAS  PubMed  Google Scholar 

  58. Cremerius U, Wildberger JE, Borchers H, et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?—results of a study in 50 patients. Urology 1999;54: 900–904.

    Article  CAS  PubMed  Google Scholar 

  59. Kole AC, Hoekstra HJ, Sleijfer DT, Nieweg OE, Schraffordt Koops H, Vaalburg W. L-[1-carbon-11]tyrosine imaging of metastatic testicular nonseminoma germ-cell tumors. J Nucl Med 1998;39:1027–1029.

    CAS  PubMed  Google Scholar 

  60. Steiner M, Prayer D, Asenbaum S, et al. Modern imaging methods for the assessment of Langerhans’ cell histiocytosis-associated neurodegenerative syndrome: case report. J Child Neurol 2005;20:253–257.

    PubMed  Google Scholar 

  61. Buchler T, Cervinek L, Belohlavek O, et al. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 2005;44:286–288.

    Article  PubMed  Google Scholar 

  62. Hoshino A, Kawada E, Ukita T, et al. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin. Am J Hematol 2004;76:236–239.

    Article  CAS  PubMed  Google Scholar 

  63. Binkovitz LA, Olshefski RS, Adler BH. Coincidence FDG-PET in the evaluation of Langerhans’ cell histiocytosis: preliminary findings. Pediatr Radiol 2003;33:598–602.

    Article  PubMed  Google Scholar 

  64. Blum R, Seymour JF, Hicks RJ. Role of 18FDG-positron emission tomography scanning in the management of histiocytosis. Leuk Lymphoma 2002;43:2155–2157.

    Article  PubMed  Google Scholar 

  65. Menzel C, Hamscho N, Dobert N, et al. PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Arch Dermatol Res 2003;295:280–283.

    Article  PubMed  Google Scholar 

  66. Lim R, Wittram C, Ferry JA, Shepard JA. FDG PET of Rosai-Dorfman disease of the thymus. AJR 2004;182:514.

    PubMed  Google Scholar 

  67. Pereira Neto CC, Roman C, Johnson M, Jagasia M, Martin WH, Delbeke D. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol 2004;6:63–67.

    Article  PubMed  Google Scholar 

  68. Moll AC, Hoekstra OS, Imhof SM, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet 2004;25:31–35.

    Article  CAS  PubMed  Google Scholar 

  69. Connolly LP, Drubach LA, Ted Treves S. Applications of nuclear medicine in pediatric oncology. Clin Nucl Med 2002;27:117–125.

    Article  PubMed  Google Scholar 

  70. Jadvar H, Alavi A, Mavi A, Shulkin BL. PET in pediatric diseases. Radiol Clin North Am 2005;43:135–152.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Hospital of University of Pennsylvania, Children’s Hospital of Philadelphia, Philadelphia, PA, 19107, USA

    Jian Qin Yu

  2. Department of Radiology, University of Toronto, Division Head of Nuclear Medicine, Research Institute, The Hospital for Sick Children, Toronto, M5G 1X8, Canada

    Martin Charron

Authors
  1. Jian Qin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Charron
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Division Head of Nuclear Medicine, Research Institute The Hospital for Sick Children University of Toronto, Toronto, M5G 1X8, Canada

    Martin Charron MD, FRCP(C) (Professor, Head of Research for Diagnostic Imaging Senior Associate Scientist) (Professor, Head of Research for Diagnostic Imaging Senior Associate Scientist)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Yu, J.Q., Charron, M. (2006). Other Tumors. In: Charron, M. (eds) Pediatric PET Imaging. Springer, New York, NY. https://doi.org/10.1007/0-387-34641-4_17

Download citation

  • DOI: https://doi.org/10.1007/0-387-34641-4_17

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-28836-9

  • Online ISBN: 978-0-387-34641-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation